High pathologic response rate of hepatic colorectal cancer metastases (HCRM) following neoadjuvant bevacizumab (Bev)-based treatment (tx).
Filippo Pietrantonio
No relevant relationships to disclose
Jorgelina Clara Coppa
No relevant relationships to disclose
Rosalba Miceli
No relevant relationships to disclose
Massimo Milione
No relevant relationships to disclose
Federica Perrone
No relevant relationships to disclose
Giuseppe Fanetti
No relevant relationships to disclose
Cotsoglou Christian
No relevant relationships to disclose
Flavia Melotti
No relevant relationships to disclose
Maria Di Bartolomeo
No relevant relationships to disclose
Vincenzo Mazzaferro
No relevant relationships to disclose
Luigi Mariani
No relevant relationships to disclose
Alessio Pellegrinelli
No relevant relationships to disclose
Claudia Bertan
No relevant relationships to disclose
Pamela Biondani
No relevant relationships to disclose
Filippo G. De Braud
No relevant relationships to disclose